Indication
Acinetobacter baumannii
2 clinical trials
5 products
Product
SulbactamClinical trial
A Randomized, Active-controlled Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus ComplexStatus: Completed, Estimated PCD: 2021-07-26
Product
ColistinProduct
DurlobactamProduct
Imipenem/CilastatinClinical trial
The Effectiveness and Safety Study of Eravacycline Combination Therapy for Multidrug-Resistant Acinetobacter Baumannii PneumoniaStatus: Recruiting, Estimated PCD: 2024-10-31
Product
Eravacycline